At the conclusion of the activity, participants should be able to
Pharmacists

• Define the concepts of primary prevention and secondary prevention in atherosclerotic cardiovascular diseases (ASCD).
• Describe the place of aspirin in patients at risk cerebrovascular accidents and peripheral arterial disease. 
• Discuss the antithrombotic therapy regimen that optimizes bleeding and thrombosis prevention in patients with chronic coronary disease.
• Discuss the place of beta blockers across the spectrum of acute and chronic coronary syndromes. 
• Explain recent evidence that supports discontinuing beta-blockers after one year in post-myocardial infarction patients.
• Recognize the need for continued professional development and interdisciplinary collaboration to better serve patients.

Pharmacy technicians 

• Define the concepts of primary prevention and secondary prevention in atherosclerotic cardiovascular diseases (ASCD).
• Identify the place of aspirin in patients at risk cerebrovascular accidents and peripheral arterial disease. 
• Identify the place of antithrombotic therapy in patients with chronic coronary disease.
• Identify the place of beta blockers in acute and chronic coronary syndromes. 
• Recognize their role in supporting pharmacist’s patient care process.